Karyopharm Therapeutics
KPTI
KPTI
154 hedge funds and large institutions have $334M invested in Karyopharm Therapeutics in 2022 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 63 increasing their positions, 39 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
154
Holders Change
+7
Holders Change %
+4.76%
% of All Funds
2.48%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
32
Increased
63
Reduced
39
Closed
24
Calls
$1.83M
Puts
$1.12M
Net Calls
+$703K
Net Calls Change
-$761K
Top Buyers
1 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$32.8M |
2 |
RCMNY
Rubric Capital Management (New York)
New York
|
+$14.6M |
3 |
AC
Armistice Capital
New York
|
+$13.1M |
4 |
![]()
Marshall Wace
London,
United Kingdom
|
+$6.97M |
5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$6.76M |